10 Jefferies Group Quest Diagnostics Trades
Jefferies Group's position in Quest Diagnostics is currently worth $4.53 Million. That's 0.09% of their equity portfolio (208th largest holding). The first Quest Diagnostics trade was made in Q4 2022. Since then Jefferies Group bought shares six more times and sold shares on three occasions. The stake costed the investor $3.39 Million, netting the investor a gain of 33% so far.
Avg closing price
Price range
Increased shares by 2.8% (+701 shares)
Q1 2025
Avg closing price
$163.98
Price range
$150.33
-
$176.95
Increased shares by 17.0% (+3.63 Thousand shares)
Q4 2024
Avg closing price
$155.59
Price range
$146.90
-
$163.89
Sold 64.1% shares (-38 Thousand shares)
Q3 2024
Avg closing price
$149.33
Price range
$136.64
-
$156.97
Increased shares by 5.9% (+3.31 Thousand shares)
Q2 2024
Avg closing price
$136.94
Price range
$125.91
-
$144.34
Increased shares by 723.5% (+49.2 Thousand shares)
Q1 2024
Avg closing price
$129.75
Price range
$123.78
-
$142.11
Sold 26.1% shares (-2.4 Thousand shares)
Q4 2023
Avg closing price
$131.47
Price range
$120.62
-
$141.12
Increased shares by 175.0% (+5.85 Thousand shares)
Q3 2023
Avg closing price
$133.24
Price range
$121.86
-
$144.92
New holding (+3.35 Thousand shares)
Q2 2023
Avg closing price
$137.86
Price range
$130.56
-
$146.84
Sold -5.17 Thousand shares
Q1 2023
Avg closing price
$143.07
Price range
$131.53
-
$155.77
New holding (+5.17 Thousand shares)
Q4 2022
Avg closing price
$143.70
Price range
$123.31
-
$157.28
